Bnph 5000 Unit Ointment is a Health Canada–registered veterinary drug (DIN 00517917) held by Vetoquinol N A Inc, containing Polymyxin B Sulfate. Health Canada lists its status as Cancelled Post Market (status date 22 Apr 2020). Nexara Health has matched 37 registrations of Polymyxin B Sulfate across 5 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 00517917 |
|---|---|
| Brand name | Bnph |
| Active ingredient | Polymyxin B Sulfate |
| Strength | 5000 Unit |
| Dosage form | Ointment |
| Route | Ophthalmic |
| Company | Vetoquinol N A Inc |
| Status | Cancelled Post Market — 22 Apr 2020 |
| Class | Veterinary |
| ATC | |
| AHFS | 04:04.92 ; 12:12.12 |
| Regulator record | Health Canada DPD entry · Product monograph |
Polymyxin B Sulfate registered in other markets
37 registrations of the same molecule in 5 national registries outside Canada (first 20 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United Kingdom | Polymyxin B 10,000units/g / Bacitracin 500units/g ointment | — | 0001 | NHS dm+d VMP | ||
| South Africa | Polysporin | Johnson & Johnson (Pty) Ltd | 10000 u/g | Oin | S1 | DoH SEP database |
| Taiwan | Bobimixyn for injection | 台灣東洋藥品工業股份有限公司六堵廠 | 凍晶乾燥注射劑 | Registered | TFDA | |
| Taiwan | Polymyxin B Sulfate | Xellia Pharmaceuticals ApS | （粉） | Registered | TFDA | |
| Taiwan | Polymyxin B Sulfate Precipitated Micronized Bulk "Pfizer" | Chas Pfizer & Co. Inc.(Pfizer Corporation) | （粉） | 已註銷 | TFDA | |
| Taiwan | Polymyxin B Sulfate Precipitated Micronized Sterile Bulk "Pfizer" | Chas Pfizer & Co. Inc.(Pfizer Corporation) | （粉） | 已註銷 | TFDA | |
| Taiwan | Polymyxin B Sulfate Sterile Micronized | Pfizer Pharmaceuticals Inc. | （粉） | 已註銷 | TFDA | |
| Taiwan | Polymyxin Eye Drops | Sigma (Pharmaceuticals) Pty Ltd. | 點眼液劑 | 已註銷 | TFDA | |
| Turkey | Polix 500.000 IU Enjeksiyonluk Cozelti Hazirlamak Icin Toz Iceren 1 Flakon | Koçak Farma İlaç Ve Ki̇mya Sanayi̇ A.ş. | Aktif | TITCK | ||
| United Kingdom | Polymyxin B 10,000units/g / Bacitracin 500units/g eye ointment | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Polymyxin B 10,000units/g / Trimethoprim 5mg/g eye ointment | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Polymyxin B 10,000units/ml / Trimethoprim 1mg/ml eye drops | — | 0001 | NHS dm+d VMP | ||
| United States | Polymyxin B | Hikma Pharmaceuticals USA Inc. | Injection, Powder, For Solution | listed | FDA NDC | |
| United States | Polymyxin B | Hikma Pharmaceuticals USA Inc. | Injection, Powder, For Solution | listed | FDA NDC | |
| United States | Polymyxin B | Sagent Pharmaceuticals | Injection, Powder, Lyophilized, For Solution | listed | FDA NDC | |
| United States | Polymyxin B | Xellia Pharmaceuticals USA LLC | Injection, Powder, For Solution | listed | FDA NDC | |
| United States | Polymyxin B | Eugia US LLC | Injection, Powder, Lyophilized, For Solution | listed | FDA NDC | |
| United States | Polymyxin B | Fosun Pharma Usa Inc | Injection, Powder, Lyophilized, For Solution | listed | FDA NDC | |
| United States | Polymyxin B | Fresenius Kabi USA, LLC | Injection, Powder, Lyophilized, For Solution | listed | FDA NDC | |
| United States | Polymyxin B | Fresenius Kabi USA, LLC | Injection, Powder, Lyophilized, For Solution | listed | FDA NDC |
See every manufacturer of Polymyxin B Sulfate worldwide →
Regulator price references for Polymyxin B Sulfate
Published list or reimbursement prices for Polymyxin B Sulfate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| South Africa | Polysporin | 10000u/1000mg | 15 | 106.35 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Bnph (DIN 00517917) marketed in Canada?
No. Health Canada lists DIN 00517917 as Cancelled Post Market as of 22 Apr 2020.
Who holds the Canadian licence for this product?
Vetoquinol N A Inc is the company of record in the Health Canada Drug Product Database.
Is Polymyxin B Sulfate registered outside Canada?
Yes — Nexara Health has matched 37 registrations in 5 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00517917, status date 2020-04-22; national medicine registries: DoH SEP database, FDA NDC, NHS dm+d VMP, TFDA, TITCK; price sources: DoH SEP database. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00517917, status date 2020-04-22; national medicine registries: DoH SEP database, FDA NDC, NHS dm+d VMP, TFDA, TITCK; price sources: DoH SEP database.
Health Canada Drug Product Database (DPD), DIN 00517917, status date 2020-04-22; national medicine registries: DoH SEP database, FDA NDC, NHS dm+d VMP, TFDA, TITCK; price sources: DoH SEP database. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.